Induced pluripotent stem cells: A new technology to study human diseases

International Journal of Biochemistry and Cell Biology

Volumn 43, Issue 6, 2011, Pages 843-846

  Vitale, Alejandra M ^a   Wolvetang, Ernst ^b   MacKay Sim, Alan ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cell; Disease; Induced pluripotent stem cells; Pluripotency; Reprogramming

Indexed keywords

ARTICLE; BLOOD; CELL DIFFERENTIATION; CELL THERAPY; DRUG SCREENING; FIBROBLAST; HEART MUSCLE CELL; HUMAN; KERATINOCYTE; LIVER CELL; MEDICAL TECHNOLOGY; NERVE CELL; PLURIPOTENT STEM CELL;

IPS;

EID: 79955903242     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2011.03.013     Document Type: Short Survey

References (27)

1. T. Aasen, A. Raya, M.J. Barrero, E. Garreta, A. Consiglio, and F. Gonzalez Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes Nat Biotechnol 26 2008 1276 1284
2. J.E. Carette, J. Pruszak, M. Varadarajan, V.A. Blomen, S. Gokhale, and F.D. Camargo Generation of iPSCs from cultured human malignant cells Blood 115 2010 4039 4042
3. E.M. Chan, S. Ratanasirintrawoot, I.H. Park, P.D. Manos, Y.H. Loh, and H. Huo Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells Nat Biotechnol 27 2009 1033 1037
4. A.D. Ebert, J. Yu, F.F. Rose Jr., V.B. Mattis, C.L. Lorson, and J.A. Thomson Induced pluripotent stem cells from a spinal muscular atrophy patient Nature 457 2009 277 280
5. H. Gai, E.L. Leung, P.D. Costantino, J.R. Aguila, D.M. Nguyen, and L.M. Fink Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts Cell Biol Int 33 2009 1184 1193
6. S. Karumbayaram, B.G. Novitch, M. Patterson, J.A. Umbach, L. Richter, and A. Lindgren Directed differentiation of human-induced pluripotent stem cells generates active motor neurons Stem Cells 27 2009 806 811
7. J.B. Kim, B. Greber, M.J. Arauzo-Bravo, J. Meyer, K.I. Park, and H. Zaehres Direct reprogramming of human neural stem cells by OCT4 Nature 461 2009 649 653
8. G. Lee, E.P. Papapetrou, H. Kim, S.M. Chambers, M.J. Tomishima, and C.A. Fasano Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs Nature 461 2009 402 406
9. C. Lengerke, M. Grauer, N.I. Niebuhr, T. Riedt, L. Kanz, and I.H. Park Hematopoietic development from human induced pluripotent stem cells Ann N Y Acad Sci 1176 2009 219 227
10. C.J. Lengner iPS cell technology in regenerative medicine Ann N Y Acad Sci 1192 2010 38 44
11. R. Lister, M. Pelizzola, Y.S. Kida, R.D. Hawkins, J.R. Nery, and G. Hon Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells Nature 471 2011 68 73
12. H. Liu, Z. Ye, Y. Kim, S. Sharkis, and Y.Y. Jang Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes Hepatology 51 2010 1810 1819
13. Y.H. Loh, S. Agarwal, I.H. Park, A. Urbach, H. Huo, and G.C. Heffner Generation of induced pluripotent stem cells from human blood Blood 113 2009 5476 5479
14. K. Miura, Y. Okada, T. Aoi, A. Okada, K. Takahashi, and K. Okita Variation in the safety of induced pluripotent stem cell lines Nat Biotechnol 27 2009 743 745
15. M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, and T. Aoi Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat Biotechnol 26 2008 101 106
16. E.P. Papapetrou, M.J. Tomishima, S.M. Chambers, Y. Mica, E. Reed, and J. Menon Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation Proc Natl Acad Sci U S A 106 2009 12759 12764
17. I.H. Park, N. Arora, H. Huo, N. Maherali, T. Ahfeldt, and A. Shimamura Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
18. A. Raya, I. Rodriguez-Piza, G. Guenechea, R. Vassena, S. Navarro, and M.J. Barrero Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells Nature 460 2009 53 59
19. K. Saha, and R. Jaenisch Technical challenges in using human induced pluripotent stem cells to model disease Cell Stem Cell 5 2009 584 595
20. F. Soldner, D. Hockemeyer, C. Beard, Q. Gao, G.W. Bell, and E.G. Cook Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 2009 964 977
21. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 (Pubitemid 44233629)
22. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, and K. Tomoda Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872 (Pubitemid 350138099)
23. D. Taura, M. Noguchi, M. Sone, K. Hosoda, E. Mori, and Y. Okada Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells FEBS Lett 583 2009 1029 1033
24. O. Tsuji, K. Miura, Y. Okada, K. Fujiyoshi, M. Mukaino, and N. Nagoshi Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury Proc Natl Acad Sci U S A 107 2010 12704 12709
25. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, and F. Lau Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 2010
26. S. Yamanaka Elite and stochastic models for induced pluripotent stem cell generation Nature 460 2009 49 52
27. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, and S. Tian Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920